List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1359 studies with search of: United States, New Mexico
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
2 Recruiting Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
Condition: Cancer
Intervention:
3 Recruiting Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Biological: trastuzumab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
4 Recruiting Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Biological: cetuximab;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
5 Active, not recruiting A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
Condition: Metastatic Breast Cancer
Interventions: Drug: bevacizumab;   Drug: chemotherapy;   Drug: placebo
6 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
7 Active, not recruiting Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Condition: Breast Cancer
Interventions: Drug: raloxifene;   Drug: tamoxifen citrate
8 Active, not recruiting Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
9 Active, not recruiting Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Conditions: Prostate Cancer;   Hormone Refractory Prostate Cancer;   One Prior Cytotoxic Chemotherapy Regimen
Interventions: Drug: Satraplatin;   Drug: Prednisone
10 Active, not recruiting Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
Condition: Kidney Cancer
Interventions: Biological: bevacizumab;   Biological: recombinant interferon alfa
11 Recruiting Phase I/II Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: Gemcitabine, Docetaxel and Bevacizumab
12 Recruiting Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: fulvestrant
13 Active, not recruiting Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Biological: bevacizumab;   Drug: FOLFOX regimen;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: adjuvant therapy
14 Completed Iressa Expanded Access Program (EAP)
Conditions: Carcinoma;   Non-Small-Cell Lung;   Metastases;   Neoplasm
Intervention: Drug: ZD1839 (Gefitinib)
15 Active, not recruiting Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy;   Radiation: radiation therapy
16 Active, not recruiting S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: S-1
17 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: pemetrexed disodium;   Drug: vinorelbine ditartrate
18 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Other: placebo
19 Active, not recruiting Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
Condition: Liver Cancer
Intervention: Drug: Gemcitabine and Oxaliplatin
20 Completed Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
Conditions: Colonic Diseases;   Cancer
Intervention: Drug: Oxaliplatin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services